Post-Treatment Assessment, Documentation, and Escalation

Key Takeaways

  • Post-treatment assessment confirms how the patient tolerated dialysis and whether goals were met: post-treatment vital signs, post-weight, access condition/hemostasis, symptoms, and alertness - the treatment is not 'done' just because the timer ended.
  • Take post-treatment vital signs sitting AND standing when ordered (orthostatic check) before the patient ambulates, because post-dialysis orthostatic hypotension is a major fall risk; a symptomatic standing BP drop must be reported and the patient kept seated.
  • Compare the post-weight to the target weight and the UF removed; a patient still above target with symptoms, or one who overshot below target, is a reportable variance.
  • Documentation must be objective and complete - delivered treatment (times, BFR, dialysate, UF removed), patient response, access outcome, variances, and notifications (who, when, why, instructions received).
  • Escalate immediately for fever/chills, chest pain, shortness of breath, persistent hypotension, active bleeding, loss of thrill/bruit, suspected hemolysis, air, or any treatment delivered outside the prescription.
Last updated: June 2026

Closing the Treatment Safely

Post-treatment assessment confirms how the patient tolerated dialysis and whether the treatment met its goals. It includes post-treatment vital signs, post-weight, access status and hemostasis, symptoms, level of alertness, and overall tolerance.

The core principle: the treatment is not over just because the timer ended. If the patient still has symptoms, abnormal vitals, an unstable access, or unmet goals, the technician keeps assessing and reporting before the patient leaves the chair.

A structured post-treatment check answers four questions:

  1. How does the patient look and feel? (vitals, symptoms, mental status, dizziness)
  2. Did we meet the goal? (post-weight vs. target weight; UF removed)
  3. Is the access safe? (hemostasis achieved, thrill/bruit present, dressing secure)
  4. Is anything outside expected limits? (variances, equipment issues, new findings)

Any 'no' or abnormal answer triggers reporting and may delay discharge from the unit until the RN evaluates.

Standing Weight, Standing Vitals, and Fall Prevention

Patients often have post-dialysis orthostatic hypotension - a BP that drops when they stand because their volume is lower after fluid removal. This is a leading cause of post-treatment falls.

  • Take post-treatment vital signs before the patient ambulates, and obtain sitting and standing (orthostatic) blood pressures when ordered or when the patient felt unstable.
  • A standing-vs-sitting systolic drop with symptoms (dizziness on standing) means keep the patient seated, recheck, and notify the RN - do not let them walk.
  • Obtain the post-treatment / standing weight on the same scale used for the pre-weight, and compare it to the target weight and the UF removed to confirm the goal was met.

Weight Comparison Logic

Post-weight vs. targetInterpretationAction
At target, asymptomaticGoal met, good toleranceRoutine documentation
Above target with symptoms/short treatmentUnder-removed (fluid still on)Report variance to RN
Below target / overshotOver-removed; hypotension riskReport; reassess BP/symptoms
Unexpectedly different from UF removedPossible scale error or data mismatchRecheck weight, report discrepancy

Never rush a symptomatic or orthostatic patient out of the chair. Standing vitals and a verified post-weight are part of the assessment, not optional extras.

Documentation and Escalation

Use objective language - chart what was seen, measured, reported, and done within role. Avoid blaming language, assumptions, and falsely reassuring phrases such as 'tolerated well' when the patient had a symptom that required intervention.

Documentation Checklist

ItemExamples to Record
Delivered treatmentStart/stop time, duration, blood flow rate, dialysate settings as required, UF removed
Patient responsePre/post vitals (incl. standing if ordered), symptoms, cramps, dizziness, pain, interventions, response
Access outcomeNeedle sites, hemostasis time, dressing, thrill/bruit per policy, bleeding problems
VariancesEarly termination, missed UF, alarms, clotting, blood loss, infiltration, heparin/medication issues observed
WeightsPre-weight, target weight, post-weight, comparison to goal
NotificationsWho was notified, time, reason, and instructions received

When to Escalate Immediately

Escalation is required when findings are outside expected limits, the patient is unstable, the access is abnormal, delivery differs from the prescription, or equipment safety is in question. Report at once:

  • Fever or chills, chest pain, shortness of breath;
  • Persistent hypotension or symptomatic orthostatic drop;
  • Active bleeding or loss of the thrill/bruit;
  • Suspected hemolysis or air embolism;
  • Significant UF/treatment variance from the prescription.

The technician reports objectively and promptly; the RN evaluates and directs the next step. Charting a value in the record is never a substitute for verbally notifying the nurse about an abnormal or unstable finding.

Confirming Adequacy and Delivered Treatment

Part of closing the treatment is confirming the patient received the adequate dose of dialysis that was prescribed. Adequacy is measured by Kt/V (a target of spKt/V ≥ 1.2 per treatment is standard) and the urea reduction ratio (URR ≥ 65%), which compare pre- and post-treatment BUN. The technician does not calculate or interpret these, but does ensure the post-treatment blood sample is drawn correctly and at the right time per protocol, because a mistimed or mishandled sample produces a falsely high or low adequacy result.

Key delivered-treatment data the technician documents accurately so adequacy can be assessed includes:

  • Actual treatment time delivered (not just the prescribed time) - interruptions reduce the dose;
  • Blood flow rate maintained and any time spent at a reduced rate;
  • UF removed versus the goal;
  • Any circuit clotting, line reversals, or recirculation that lowered effective clearance.

A treatment that was shortened, run at a reduced blood flow, or interrupted by clotting delivered less than the prescribed dose, and that variance is documented and reported. The exam connects these dots: incomplete time or flow means an inadequate treatment, which is a reportable outcome - not something to paper over with 'tolerated well.'

Putting It Together

The well-closed treatment leaves a clear record: the patient is stable with checked standing vitals, the post-weight is compared to target, the access has hemostasis and a present thrill, all variances are reported, the adequacy sample is correct, and every abnormal finding was verbally handed off to the RN. That complete, objective close-out is exactly what the CCHT exam rewards - and the vague, delayed, or falsely reassuring version is what it penalizes.

Test Your Knowledge

After treatment, a patient's sitting BP is 118/72, but on standing it falls to 92/58 and the patient reports dizziness. What is the most appropriate action?

A
B
C
D
Test Your Knowledge

At the end of treatment a patient's post-weight is 1.2 kg above the target weight, the treatment was shortened by alarms, and the patient reports mild shortness of breath. How should the technician handle this?

A
B
C
D
Test Your Knowledge

Which post-treatment finding requires IMMEDIATE escalation rather than routine end-of-shift documentation?

A
B
C
D
Test Your Knowledge

A technician notices the patient became briefly hypotensive and received a saline bolus during treatment, then recovered. The technician charts 'patient tolerated treatment well.' What should be corrected?

A
B
C
D